All Stories

  1. A Cross‐Sectional Study Exploring Patient Experiences, Unmet Needs and Desired Support in Those With Olfactory Dysfunction
  2. A Prospective Cohort Study Investigating the Role of a Screening Smell and Taste Test in Patients Following Head Injury
  3. The APOLLO Trial: A P roof-of-Concept Study for Vitamin A Nasal Drops in COVID-19 Related Post-Infectious Ol factory Dysfunction
  4. Digital intervention for smell training: a real-world study on engagement, adherence, and behavioural dynamics
  5. Investigating idiopathic anosmia as a prodromal state of Parkinson’s disease
  6. The need to promote smell health across the globe
  7. Endoscopic Management of Sinus Neoplasia: An Experience of a Dedicated Sinus Centre in Image-Guided Surgery of Inverted Papillomata
  8. A trial comparing sinus surgery and antibiotics in adults with chronic rhinosinusitis
  9. The need to promote smell health across the globe
  10. Exploring barriers to seeking support for Smell and Taste Disorders (SATDs) amongst minority communities in the UK
  11. Gustatory dysfunction in dementia and cognitive decline
  12. Olfactory loss and dysfunction in dementia and cognitive decline
  13. A New Approach to Dementia
  14. \fancyhead [R] Smell and Taste Disorder Impact on Eating Habits: a cross-sectional observational study
  15. The Development and Validation of the Smell‐Qx Questionnaire, Based on a Systematic Review of the Literature and the COMET Initiative on the Development of Core Outcome Sets for Clinical Trials in Olfactory Disorders
  16. Epidemiology of Cholesteatoma in the UK Biobank
  17. British Skull Base Society Consensus on Vestibular Schwannoma Surveillance
  18. Nasal endoscopy score thresholds to trigger consideration of chronic rhinosinusitis treatment escalation and implications for disease control
  19. Epidemiology of Cholesteatoma in the UK Biobank
  20. Smell Above All: Envisioning Smell-Centred Future Worlds
  21. Impact of olfactory disorders on personal safety and well-being: a cross-sectional observational study
  22. Evaluation of Hyperbaric Oxygen Therapy as an Adjuvant Treatment for Necrotising Otitis Externa: Retrospective, observational, case-control study.
  23. The Clinical Course of Paranasal Sinus Mucocoeles—A Retrospective Case Series
  24. Obesity and Olfaction
  25. Abstracts from the 56th European Society of Human Genetics (ESHG) Conference: Hybrid Posters
  26. International clinical assessment of smell: An international, cross‐sectional survey of current practice in the assessment of olfaction
  27. EUFOREA/EPOS2020 statement on the clinical considerations for chronic rhinosinusitis with nasal polyps care
  28. Delivery of Topical Drugs to the Olfactory Cleft
  29. Endoscopic management of sinus neoplasia: case series of image-guided surgery of inverted papillomata and recommended best practice for managing cases.
  30. Everything smells like poo, landfill, and rotten food”: A retrospective case report using Clinical Emotional Freedom Techniques (EFT) for parosmia following COVID-19
  31. A double-blinded randomised controlled trial of vitamin A drops to treat post-viral olfactory loss: study protocol for a proof-of-concept study for vitamin A nasal drops in post-viral olfactory loss (APOLLO)
  32. Position paper on olfactory dysfunction: 2023
  33. Consensus criteria for chronic rhinosinusitis disease control: an international Delphi Study
  34. Prevalence and Associated Factors of Medication Non-Adherence in CRS Patients following Endoscopic Sinus Surgery
  35. Understanding the Impact of Chronic Rhinosinusitis with Nasal Polyposis on Smell and Taste: An International Patient Experience Survey
  36. Assessment of COVID-19-related olfactory dysfunction and its association with psychological, neuropsychiatric, and cognitive symptoms
  37. Exploring Endotypes in Chronic Rhinosinusitis (ExpRess): Protocol for a cohort study
  38. Systematic Review of Protein Biomarkers in Adult Patients With Chronic Rhinosinusitis
  39. Impact of olfactory disorders on personal safety & wellbeing: a cross-sectional observational study
  40. Developing a core outcome set for clinical trials in olfactory disorders: a COMET initiative
  41. Nose Gym: An Interactive Smell Training Solution
  42. Olfactory Nomenclature: An Orchestrated Effort to Clarify Terms and Definitions of Dysosmia, Anosmia, Hyposmia, Normosmia, Hyperosmia, Olfactory Intolerance, Parosmia, and Phantosmia/Olfactory Hallucination
  43. Whole exome sequencing study identifies candidate loss of function variants and locus heterogeneity in familial cholesteatoma
  44. Health-Related Quality of Life Impairment Among Patients with Severe Chronic Rhinosinusitis with Nasal Polyps in the SINUS-24 Trial
  45. Commentary on Patient Advocacy and Research Priorities in Olfactory and Gustatory Disorders
  46. Olfactory Disorders Questionnaire: Scaling severity of quality‐of‐life impact
  47. The Nose and the Effects of SARS-CoV-2 Pandemic
  48. The growing burden of long COVID in the United Kingdom: Insights from the UK Coronavirus Infection Survey
  49. The EUFOREA pocket guide for chronic rhinosinusitis
  50. High prevalence of persistent smell loss and qualitative smell dysfunction during the coronavirus disease 2019 (COVID‐19) pandemic in the United States: Urgent need for clinical trials
  51. Investigations and Outcomes for Olfactory Disorders
  52. Manipulation under anaesthesia of fractured nasal bones – a 10-year retrospective study
  53. The burden of olfactory dysfunction during the COVID-19 pandemic in the United Kingdom
  54. Ask the Experts: An International Consensus on Managing Post-Infectious Olfactory Dysfunction Including COVID-19
  55. Establishing UK research priorities in smell and taste disorders: A James Lind alliance priority setting partnership
  56. Interventions for the prevention of persistent post-COVID-19 olfactory dysfunction
  57. The use of MRI in a tertiary smell and taste clinic: Lessons learned based on a retrospective analysis
  58. Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): In‐depth sinus surgery analysis
  59. Whole exome sequencing study identifies candidate loss of function variants and locus heterogeneity in familial cholesteatoma
  60. The COVANOS trial – insight into post-COVID olfactory dysfunction and the role of smell training
  61. When is Magnetic Resonance Imaging most beneficial in olfactory dysfunction? A retrospective review of a tertiary referral smell and taste clinic
  62. Establishing UK Research Priorities In Smell and Taste Disorders: A James Lind Alliance Priority Setting Partnership
  63. A follow-up on quantitative and qualitative olfactory dysfunction and other symptoms in patients recovering from COVID-19 smell loss
  64. International consensus statement on allergy and rhinology: Olfaction
  65. Effects of fluid and drinking on pneumonia mortality in older adults: A systematic review and meta-analysis
  66. Interventions for the treatment of persistent post-viral olfactory dysfunction
  67. Observational retrospective study calculating health service costs of patients receiving surgery for chronic rhinosinusitis in England, using linked patient-level primary and secondary care electronic data
  68. Olfaction and CSF Leak
  69. 918 Nasal Packing Duration in The Management of Epistaxis: A Cohort Study
  70. Interventions for the prevention of persistent post-COVID-19 olfactory dysfunction
  71. Cultural Adaptation and Validity of the Sniffin’ Sticks Psychophysical Test for the UK Setting
  72. Barriers to effective health care for patients who have smell or taste disorders
  73. Patient perspectives about participation in a chronic rhinosinusitis trial during the COVID pandemic: a qualitative study.
  74. Clinical Olfactory Working Group consensus statement on the treatment of postinfectious olfactory dysfunction
  75. British Rhinological Society Consensus Guidance on the use of biological therapies for chronic rhinosinusitis with nasal polyps
  76. Socioeconomic, comorbidity, lifestyle, and quality of life comparisons between chronic rhinosinusitis phenotypes
  77. Systemic corticosteroids in coronavirus disease 2019 (COVID‐19)‐related smell dysfunction: an international view
  78. Interventions for the prevention of persistent post-COVID-19 olfactory dysfunction
  79. International consensus statement on allergy and rhinology: rhinosinusitis 2021
  80. Barriers to Effective Healthcare for Patients Who Have Smell or Taste Disorders
  81. British Rhinological Society Consensus Guidance on the use of biological therapies for Chronic Rhinosinusitis with Nasal Polyps
  82. Interventions for the treatment of persistent post-COVID-19 olfactory dysfunction
  83. Admission avoidance in acute epistaxis: A prospective national audit during the initial peak of the COVID‐19 pandemic
  84. Health-Related Quality of Life Impairment Among Patients With Severe Chronic Rhinosinusitis With Nasal Polyps in the SINUS-24 Trial
  85. Evaluation of Smoking as a Modifying Factor in Chronic Rhinosinusitis
  86. Paediatric tonsillectomy in England: A cohort study of clinical practice and outcomes using Hospital Episode Statistics data (2008‐2019)
  87. Maximising recruitment to a randomised controlled trial for chronic rhinosinusitis using qualitative research methods: the MACRO conversation study
  88. A systematic review to examine the relationship between objective and patient‐reported outcome measures in sinonasal disorders: recommendations for use in research and clinical practice
  89. Qualitative Olfactory Disorders: Patient Experiences and Self-Management
  90. Corrigendum to: More Than Smell—COVID-19 Is Associated With Severe Impairment of Smell, Taste, and Chemesthesis
  91. Patient Experiences of Postinfectious Olfactory Dysfunction
  92. Recent Smell Loss Is the Best Predictor of COVID-19 Among Individuals With Recent Respiratory Symptoms
  93. Course of symptoms for loss of sense of smell and taste over time in one thousand forty‐one healthcare workers during the Covid‐19 pandemic: Our experience
  94. Admission avoidance in tonsillitis and peritonsillar abscess: A prospective national audit during the initial peak of the COVID‐19 pandemic
  95. Comparison of COVID-19 and common cold chemosensory dysfunction
  96. Parosmia is Associated with Relevant Olfactory Recovery After Olfactory Training
  97. Socioeconomic, comorbidity, lifestyle and quality of life comparisons between chronic rhinosinusitis phenotypes: Data from the National Chronic Rhinosinusitis Epidemiology Study
  98. Patient Experiences of Post-Infectious Olfactory Dysfunction
  99. Management of new onset loss of sense of smell during the COVID‐19 pandemic ‐ BRS Consensus Guidelines
  100. Is loss of sense of smell a diagnostic marker in COVID‐19: A systematic review and meta‐analysis
  101. Smoking as a modifying factor in chronic rhinosinusitis: Data from the Chronic Rhinosinusitis Epidemiology Study
  102. Olfactory Loss of Function as a Possible Symptom of COVID-19
  103. Defining appropriateness criteria for endoscopic sinus surgery in the management of adult dental implant patients with incidental maxillary sinus findings on conebeam computed tomography
  104. Anosmia and hyposmia in health-care workers with undiagnosed SARS-CoV-2 infection
  105. The best COVID-19 predictor is recent smell loss: a cross-sectional study
  106. Barriers to accessing healthcare in patients with olfactory and gustatory disorders
  107. Qualitative Olfactory Disorders: Patient experiences and self-management
  108. More Than Smell—COVID-19 Is Associated With Severe Impairment of Smell, Taste, and Chemesthesis
  109. Management of new onset anosmia during the COVID pandemic - BRS Consensus Guidelines
  110. Parosmia is associated with relevant olfactory recovery after olfactory training
  111. The impact of patients losing their sense of smell
  112. Anosmia as a presenting symptom of SARS-CoV-2 infection in healthcare workers – A systematic review of the literature, case series, and recommendations for clinical assessment and management
  113. Cholesteatoma and family history: An international survey
  114. The Socioeconomic Cost of Chronic Rhinosinusitis Study
  115. Biologics for chronic rhinosinusitis
  116. European Position Paper on Rhinosinusitis and Nasal Polyps 2020
  117. Biologics for chronic rhinosinusitis
  118. An unmet need: Patients with smell and taste disorders
  119. 139 Risk of parkinson’s in idiopathic anosmia
  120. Lacrimal sac primary squamous cell carcinoma with synchronous tonsillar primary squamous cell carcinoma
  121. Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials
  122. Antibiotic usage in chronic rhinosinusitis: analysis of national primary care electronic health records
  123. Optimising trial outcomes and patient retention for the MACRO trial for chronic rhinosinusitis
  124. The genetics of cholesteatoma study. Loss‐of‐function variants in an affected family
  125. What is the most appropriate treatment for chronic rhinosinusitis?
  126. Validation of the olfactory disorders questionnaire for English‐speaking patients with olfactory disorders
  127. EPOS2020: development strategy and goals for the latest European Position Paper on Rhinosinusitis
  128. Exploring the association between ingestion of foods with higher potential salicylate content and symptom exacerbation in chronic rhinosinusitis. Data from the National Chronic Rhinosinusitis Epidemiology Study
  129. Clarithromycin and endoscopic sinus surgery for adults with chronic rhinosinusitis with and without nasal polyps: study protocol for the MACRO randomised controlled trial
  130. Expert panel process to optimise the design of a randomised controlled trial in chronic rhinosinusitis (the MACRO programme)
  131. Chronic rhinosinusitis: a qualitative study of patient views and experiences of current management in primary and secondary care
  132. Unilateral visual loss resulting from orbital encroachment of an ethmoidal juvenile trabecular ossifying fibroma
  133. Risk of mortality and cardiovascular events following macrolide prescription in chronic rhinosinusitis patients: a cohort study using linked primary care electronic health records
  134. EPOS2020: development strategy and goals for the latest European Position Paper on Rhinosinusitis
  135. Wooden spatula sinusitis following maxillary expansion surgery
  136. Management strategies for chronic rhinosinusitis: a qualitative study of GP and ENT specialist views of current practice in the UK
  137. Topical and systemic antifungal therapy for chronic rhinosinusitis
  138. Development of an International Odor Identification Test for Children: The Universal Sniff Test
  139. Prevalence of asthma, aspirin sensitivity and allergy in chronic rhinosinusitis: data from the UK National Chronic Rhinosinusitis Epidemiology Study
  140. Saline irrigation for allergic rhinitis
  141. Faculty of 1000 evaluation for Monoclonal antibodies for the treatment of chronic rhinosinusitis with nasal polyposis: a systematic review.
  142. Eustachian tube symptoms are frequent in chronic rhinosinusitis and respond well to endoscopic sinus surgery
  143. Endonasal Approaches to Maxillary Sinus
  144. The use of nasal sprays and rinses in patients with chronic sinus disease
  145. The British Rhinological Society multidisciplinary consensus recommendations on the hospital management of epistaxis
  146. Initial assessment in the management of adult epistaxis: systematic review
  147. EUFOREA Rhinology Research Forum 2016: report of the brainstorming sessions on needs and priorities in rhinitis and rhinosinusitis
  148. Health care usage and quality of life reporting in chronic sinusitis patients
  149. The genetics of cholesteatoma. A systematic review using narrative synthesis
  150. Position paper on olfactory dysfunction
  151. Chronic rhinosinusitis and mood disturbance
  152. A randomised controlled trial of sodium citrate spray for non-conductive olfactory disorders
  153. Saline irrigation for allergic rhinitis
  154. Cochrane Corner: Extracts from The Cochrane Library: Intranasal Steroids for Chronic Rhinosinusitis
  155. CHronic Rhinosinusitis Outcome MEasures (CHROME), developing a core outcome set for trials of interventions in chronic rhinosinusitis
  156. Position paper on olfactory dysfunction
  157. Chronic rhinosinusitis and mood disturbance
  158. EUFOREA Rhinology Research Forum 2016: report of the brainstorming sessions on needs and priorities in rhinitis and rhinosinusitis
  159. A cross sectional analysis of a case-control study about quality of life in CRS in the UK; a comparison between CRS subtypes
  160. Intranasal sodium citrate solution improves olfaction in post-viral hyposmia
  161. A case-control study of medical, psychological and socio-economic factors influencing the severity of chronic rhinosinusitis
  162. Identifying the most important outcomes for systematic reviews of interventions for rhinosinusitis in adults: working with Patients, Public and Practitioners
  163. A cross sectional analysis of a case-control study about quality of life in CRS in the UK; a comparison between CRS subtypes
  164. Intranasal sodium citrate solution improves olfaction in post-viral hyposmia
  165. Topical and systemic antifungal therapy for chronic rhinosinusitis
  166. The value of a feasibility study into long-term macrolide therapy in chronic rhinosinusitis
  167. SNOT-22 in a control population
  168. Current practice in septal surgery and adjunctive turbinate reduction - A multisite experience in 226 consecutive cases
  169. A case-control study of medical, psychological and socio-economic factors influencing the severity of chronic rhinosinusitis
  170. Genetics of Cholesteatoma Project
  171. Short-course oral steroids alone for chronic rhinosinusitis
  172. Short-course oral steroids as an adjunct therapy for chronic rhinosinusitis
  173. Different types of intranasal steroids for chronic rhinosinusitis
  174. Systemic and topical antibiotics for chronic rhinosinusitis
  175. Saline irrigation for chronic rhinosinusitis
  176. Intranasal steroids versus placebo or no intervention for chronic rhinosinusitis
  177. Chronic rhinosinusitis and mood disturbance
  178. Long term quality of life in patients with fungal sinus disease
  179. Identifying the most important outcomes for systematic reviews of interventions for rhinosinusitis in adults: working with Patients, Public and Practitioners
  180. Chronic rhinosinusitis: patient experiences of primary and secondary care - a qualitative study
  181. Anatomic findings in revision endoscopic sinus surgery: Case series and review of contributory factors
  182. Short-course oral steroids as an adjunct therapy for chronic rhinosinusitis
  183. Systemic and topical antibiotics for chronic rhinosinusitis
  184. Saline irrigation for chronic rhinosinusitis
  185. Different types of intranasal steroids for chronic rhinosinusitis
  186. Intranasal steroids versus placebo or no intervention for chronic rhinosinusitis
  187. Short-course oral steroids alone for chronic rhinosinusitis
  188. Abstracts of the 2015 Annual Meeting 4-6 September 2015 Telford International Centre UK
  189. The impact of commissioning for rhinosinusitis in England
  190. Investigation of nasal diseases
  191. British Rhinological Society 14th Annual Meeting The Central Convention Centre, Manchester. 15th May 2015
  192. The burden of revision sinonasal surgery in the UK--data from the Chronic Rhinosinusitis Epidemiology Study (CRES): a cross-sectional study
  193. Authors’ response
  194. Hyposmia
  195. Assessing the sense of smell
  196. Cost-Effective Surgical Intervention in Chronic Rhinosinusitis
  197. Bilateral glossopharyngeal nerve palsy following tonsillectomy: a very rare and difficult complication of a common procedure
  198. Managing chronic rhinosinusitis and respiratory disease: a qualitative study of triggers and interactions
  199. Getting involved in ENT clinical research in the UK; how can the NIHR Clinical Research Network help?
  200. The Impact of Olfactory Disorders in the United Kingdom
  201. Chronic Rhinosinusitis and Mood Disturbance
  202. Management of CRSwNPs Surgically
  203. Olfactory Improvement and Decline in Patients with Posttraumatic Olfactory Dysfunction
  204. SNOT-22 in a Control Population
  205. Anatomy and Physiology of the Olfactory and Gustatory Systems
  206. Cerebrospinal Fluid Rhinorrhoea
  207. Ciliary Motility Disorders
  208. Clinical Governance and Audit
  209. Complications of Sinusitis
  210. Endoscopic Sinus Surgery and Complications
  211. Epistaxis
  212. European Position Paper on Rhinosinusitis and Nasal Polyps
  213. Facial Flaps, Scars, and Keloids
  214. Facial Fractures and Swelling
  215. Fungal Sinus Disease
  216. Headache and Facial Pain
  217. Medical Statistics
  218. Microbiology of ENT
  219. Olfactory and Gustatory Disorders
  220. Sinonasal Anatomy and Physiology
  221. Tumours of the Nose and Paranasal Sinuses
  222. Retronasal testing of olfactory function: an investigation and comparison in seven countries
  223. Using a passive coordinate measurement arm for motion tracking of a rigid endoscope for augmented-reality image-guided surgery
  224. Unilateral cacosmia: a presentation of maxillary fungal infestation
  225. When mealtime is the most dreaded moment of your day
  226. Pneumatisation of turbinates and paranasal sinuses in children: case report
  227. A double-blinded randomised controlled trial of the effects of sodium citrate on olfactory thresholds
  228. A double-blind randomised controlled trial of gloved versus ungloved merocel middle meatal spacers for endoscopic sinus surgery
  229. Epistaxis Secondary to an Oncocytoma of the Anterior Skull Base
  230. Skull base oncocytoma presenting as epistaxis: an unusual presentation of a rare tumour successfully managed with active surveillance
  231. A useful tool - systematic checklist for evaluating sinus scans
  232. Validation study of the “Sniffin’ Sticks” olfactory test in a British population: a preliminary communication
  233. A double-blind randomised controlled trial of gloved versus ungloved merocel middle meatal spacers for endoscopic sinus surgery
  234. Allergic fungal rhinosinusitis - a new staging system
  235. Allergic fungal rhinosinusitis - a new staging system
  236. Olfactory Dysfunction in Allergic Fungal Rhinosinusitis
  237. Selecting the Best Approach to the Frontal Sinus
  238. Nanomedicine in otorhinolaryngology: what does the future hold?
  239. Endoscopic management of inverted papillomas: long-term results, the St. Pauls Sinus Centre experience
  240. Endoscopic frontal sinusotomy-Preventing recurrence or a route to revision?
  241. Tumefactive fibroinflammatory lesion of the frontal sinus
  242. The Leicester semi-automated olfactory threshold test--a psychophysical olfactory test for the 21st century
  243. SUBJECTS AND METHODS
  244. Periorbital oedema and surgical emphysema, an unusual complication of a dental procedure: a case report
  245. Proximal Lacrimal Obstruction – A Review
  246. The superosmic phenomenon
  247. The Leicester Olfactometer
  248. Does methicillin-resistantStaphylococcus aureushave a significant role in the peri-operative course of patients undergoing rhinological surgery?
  249. ENT cases seen at a local ‘walk-in centre’: a one year review
  250. Does hormone replacement therapy in post-menopausal women have any effect upon nasal physiology?
  251. A brief history of olfaction and olfactometry
  252. The superosmic phenomenon
  253. Olfactory clearance: what time is needed in clinical practice?
  254. The Effect of Female Hormone Manipulation on Nasal Physiology
  255. R142: The Effects of Sensory Deprivation on Olfactory Thresholds
  256. R152: Olfactory Adaptation and Clearance in Clinical Practice
  257. Bronchiectasis and sino-nasal disease: a review
  258. What is the short term effect of perfumes on olfactory thresholds?
  259. Which variables matter in smell tests in the clinic?
  260. Does the benefit of adenoidectomy in addition to ventilation tube insertion persist long-term?
  261. Methicillin resistant Staphylococcus aureus: is it a problem for nasal surgery?
  262. Randomised-controlled study comparing post-operative pain between coblation palatoplasty and laser palatoplasty
  263. Comparison of Subjective Perception with Objective Measurement of Olfaction
  264. Response to Rachmanidou
  265. Timing of tracheostomy in adult patients: Potential ramifications are alarming
  266. Variability of vascularity in nasal mucosa as demonstrated by CD34 immunohistochemistry
  267. Do our Noses Lead Us Away from the Scent?
  268. Superosmia: A New Vomeronasal Organ Mediated Phenomenon?
  269. A double-blinded randomized controlled trial of coblation versus conventional dissection tonsillectomy on post- operative symptoms
  270. Is there a role for more day-case septal surgery?
  271. Erratum
  272. Canalicular adenoma of the parotid gland
  273. Paediatric retropharyngeal abscess
  274. Which solvent for olfactory testing?
  275. Nasal physiological changes during pregnancy
  276. The effect of the steroid sex hormones on the nasal airway during the normal menstrual cycle1
  277. The effect of temperature, humidity and peak inspiratory nasal flow on olfactory thresholds
  278. Protocol biopsy of the stable renal transplant: a multicenter study of methods and complication rates
  279. Subjects and methods
  280. Hyposmia